Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Gross Margin (2020 - 2024)

LifeStance Health (LFST) has disclosed Gross Margin for 5 consecutive years, with 32.12% as the latest value for Q3 2024.

  • Quarterly Gross Margin rose 313.0% to 32.12% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 31.2% through Sep 2024, up 317.0% year-over-year, with the annual reading at 28.62% for FY2023, 104.0% up from the prior year.
  • Gross Margin for Q3 2024 was 32.12% at LifeStance Health, up from 31.31% in the prior quarter.
  • The five-year high for Gross Margin was 32.49% in Q3 2020, with the low at 26.69% in Q1 2022.
  • Average Gross Margin over 5 years is 29.67%, with a median of 29.69% recorded in 2023.
  • The sharpest move saw Gross Margin crashed -405bps in 2022, then surged 397bps in 2024.
  • Over 5 years, Gross Margin stood at 32.49% in 2020, then fell by -12bps to 28.55% in 2021, then decreased by -4bps to 27.33% in 2022, then rose by 9bps to 29.69% in 2023, then rose by 8bps to 32.12% in 2024.
  • According to Business Quant data, Gross Margin over the past three periods came in at 32.12%, 31.31%, and 31.53% for Q3 2024, Q2 2024, and Q1 2024 respectively.